Zoetis Inc.
ZTS Health Care · Pharmaceuticals & BiotechnologyEach grade is a single reported quarter's assessment, never an average — a card shows the grade at the newest quarter in view, so it follows the period and range controls above. Latest scored quarter: 2026-06-30.
▼−46 over range · as of 2026-06-30
Revenue -0.2% YoY, earnings -4.8% YoY · sector avg 66
▲+6 over range · as of 2026-06-30
28.0% net margin, 84% return on equity, 24% free-cash-flow margin, profitable in 8 of last 8 quarters · sector avg 45
▼−13 over range · as of 2026-06-30
Net debt 1.9x EBITDA, 3.1x current ratio · sector avg 59
Trailing twelve months · ending 2026-06-30 · green = improving · click a row to chart it
Revenue $9.5B −0.1% Gross margin 71.7% −0.1pp Operating margin — — Net margin 27.7% −0.3pp CHARTED Net income $2.6B −1.3%Filings
TTM 23-09 → TTM 26-06 · following the period bar 16 match| Year | Q1 | Q2 | Q3 | FY |
|---|---|---|---|---|
| 2026 | 10-Q Q1 2026 | 10-Q Q2 2026 | no filing | no filing |
| 2025 | 10-Q Q1 2025 | 10-Q Q2 2025 | 10-Q Q3 2025 | 10-K FY 2025 |
| 2024 | 10-Q Q1 2024 | 10-Q Q2 2024 | 10-Q Q3 2024 | 10-K FY 2024 |
| 2023 | 10-Q Q1 2023 | 10-Q Q2 2023 | 10-Q Q3 2023 | 10-K FY 2023 |
| 2022 | no filing | no filing | no filing | 10-K FY 2022 |
All 16 filings
10-K FY 2024 2025-02-13 Pro → 10-Q Q3 2024 2024-11-04 Pro → 10-Q Q2 2024 2024-08-06 Pro → 10-Q Q1 2024 2024-05-02 Pro → 10-K FY 2023 2024-02-13 Pro → 10-Q Q3 2023 2023-11-02 Pro → 10-Q Q2 2023 2023-08-08 Pro → 10-Q Q1 2023 2023-05-04 Pro → 10-K FY 2022 2023-02-14 Pro → 10-Q/A Q2covered period not dated yet — listed by filing date 2019-08-09 Pro →Filing-level fact detail is a Pro feature. The grades and figures above are free. See Pro plans
Trends
| Period | Period end | Revenue |
|---|---|---|
| TTM 23-09 | 2023-09-30 | $8.4B |
| TTM 23-12 | 2023-12-31 | $8.5B |
| TTM 24-03 | 2024-03-31 | $8.7B |
| TTM 24-06 | 2024-06-30 | $8.9B |
| TTM 24-09 | 2024-09-30 | $9.2B |
| TTM 24-12 | 2024-12-31 | $9.3B |
| TTM 25-03 | 2025-03-31 | $9.3B |
| TTM 25-06 | 2025-06-30 | $9.4B |
| TTM 25-09 | 2025-09-30 | $9.4B |
| TTM 25-12 | 2025-12-31 | $9.5B |
| TTM 26-03 | 2026-03-31 | $9.5B |
| TTM 26-06 | 2026-06-30 | $9.5B |
| Period | Period end | Net income |
|---|---|---|
| TTM 23-09 | 2023-09-30 | $2.3B |
| TTM 23-12 | 2023-12-31 | $2.3B |
| TTM 24-03 | 2024-03-31 | $2.4B |
| TTM 24-06 | 2024-06-30 | $2.3B |
| TTM 24-09 | 2024-09-30 | $2.4B |
| TTM 24-12 | 2024-12-31 | $2.5B |
| TTM 25-03 | 2025-03-31 | $2.5B |
| TTM 25-06 | 2025-06-30 | $2.6B |
| TTM 25-09 | 2025-09-30 | $2.6B |
| TTM 25-12 | 2025-12-31 | $2.7B |
| TTM 26-03 | 2026-03-31 | $2.7B |
| TTM 26-06 | 2026-06-30 | $2.6B |
| Period | Period end | Net margin |
|---|---|---|
| TTM 23-09 | 2023-09-30 | 27.2% |
| TTM 23-12 | 2023-12-31 | 27.4% |
| TTM 24-03 | 2024-03-31 | 27.4% |
| TTM 24-06 | 2024-06-30 | 26.3% |
| TTM 24-09 | 2024-09-30 | 26.6% |
| TTM 24-12 | 2024-12-31 | 26.9% |
| TTM 25-03 | 2025-03-31 | 26.9% |
| TTM 25-06 | 2025-06-30 | 27.6% |
| TTM 25-09 | 2025-09-30 | 28.0% |
| TTM 25-12 | 2025-12-31 | 28.2% |
| TTM 26-03 | 2026-03-31 | 28.0% |
| TTM 26-06 | 2026-06-30 | 27.7% |
Grade history
Point-in-time: each period shows the grade of the quarter it ends at — grades are never summed or averaged across a window.
Hover to read every grade at a period · shared with the trends chart · axis fixed 0–100
| Period | Period end | Growth | Quality | Safety |
|---|---|---|---|---|
| TTM 23-09 | 2023-09-30 | 60 | 74 | 83 |
| TTM 23-12 | 2023-12-31 | 58 | 77 | 78 |
| TTM 24-03 | 2024-03-31 | 68 | 79 | 80 |
| TTM 24-06 | 2024-06-30 | 49 | 82 | 82 |
| TTM 24-09 | 2024-09-30 | 62 | 83 | 84 |
| TTM 24-12 | 2024-12-31 | 45 | 80 | 69 |
| TTM 25-03 | 2025-03-31 | 35 | 82 | 63 |
| TTM 25-06 | 2025-06-30 | 45 | 83 | 61 |
| TTM 25-09 | 2025-09-30 | 27 | 79 | 73 |
| TTM 25-12 | 2025-12-31 | 29 | 83 | 74 |
| TTM 26-03 | 2026-03-31 | 27 | 81 | 72 |
| TTM 26-06 | 2026-06-30 | 14 | 81 | 70 |